Počet záznamov: 1
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an Infectious Diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52)
SYS 0145899 LBL 00000naa^^22^^^^^^^^450 005 20180529114920.7 100 $a 20180503d2018 m y0sloy0103 ba 101 0-
$a eng 102 $a SK 200 1-
$a ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an Infectious Diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52) $f Drgona L. ... [et al.] 305 $a Clinical Microbiology and Infection, Fe. 12 (2018) 463 -1
$1 001 sllk_un_cat*0144849 $1 011 $a 1336-8176 $1 200 1 $a Onkológia $v Roč. 13, č. 1 (2018), s. 73 $1 210 $a Bratislava $c SOLEN $d 2018 $1 215 $a s. 5-74 606 1-
$3 sllk_un_auth*d003141 $a choroby infekčné $2 mesh 606 2-
$3 sllk_un_auth*d001691 $a terapia biologická $2 mesh 606 2-
$3 sllk_un_auth*d058990 $a terapia molekulárne cielená $2 mesh 606 2-
$3 sllk_un_auth*d000911 $a protilátky monoklonálne $2 mesh 608 $3 sllk_un_auth*d004740 $a abstrakt v angličtine $2 mesh 701 -1
$3 sllk_un_auth*p0063373 $a Drgoňa $b Ľuboš $p II. Onkologická klinika LFUK a NOÚ, Bratislava $4 100 711 02
$3 sllk_un_auth*0012742 $a Redakcia Onkológia $4 010 801 -0
$a SK $b BA006 $c 20180503 $g AACR2
Počet záznamov: 1